Genesis Cancer Care Queensland expands stereotactic programme

art stereotactic

Dr Art Kaminski, GCCQ Radiation Oncologist and Dr Marosh Vrtik, Thoracic Surgeon

The St Andrew’s Thoracic Oncology Multi-Disciplinary team met for the final time on December 7th at the Regatta Hotel.
Dr Art Kaminski presented a review of the evolving role of stereotactic radiotherapy in a number of lung cancer settings;

The established practice of treating peripheral tumours, further supported by the presentation of the Australasian CHISEL trial results at the 2017 World Lung Cancer Congress held in Osaka, Japan

Central tumours treated according to the Bezjak or Haasbeek protocols as reached by consensus at the 2017 Annual Genesis Scientific Meeting held in Sydney

Oligometastatic disease (with up to three lesions) as treated in the SAFRON trials and upcoming CORE study

Dominant lesions treated with SABR in the setting of widely metastatic disease as part of the NIVORAD trial

The group is looking forward to utilising the expanded stereotactic programme in the new year.
For further enquiries please contact Genesis Cancer Care Queensland on 3870 4366

Follow us on Facebook

Genesis Logo Small.pngGenesisCare is Australia’s leading provider of radiation oncology, cardiology and sleep treatments. We exist to fill the treatment gap for the biggest disease burdens in Australia - cancer and cardiovascular disease - in an environment of substantial unmet demand from an ageing population. Click here to learn more